Condition
Lobular Breast Carcinoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 15 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
15 shown18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast CancerNCT05982496 · 2026-06-09
RECRUITINGNegative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort StudyNCT07613151 · 2026-05-01
RECRUITINGA Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerNCT07483307 · 2026-03-13
RECRUITINGBiomarkers to Detect Endocrine Therapy ResistanceNCT06067503 · 2024-04-30
RECRUITINGImproving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)NCT05964504 · 2023-12-20
RECRUITINGA Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueNCT05837767 · 2023-07-24
RECRUITINGA Study Comparing Cancer Imaging Approaches in People With Lobular Breast CancerNCT06557148 · 2024-08-13
ACTIVE_NOT_RECRUITINGInitial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CTNCT05931302 · 2023-11-16
ACTIVE_NOT_RECRUITINGLobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer PatientsNCT05410951 · 2022-05-16
ACTIVE_NOT_RECRUITINGCrizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid TumoursNCT03620643 · 2019-05-09
COMPLETEDLiving Well After Breast SurgeryNCT03834532 · 2019-02-18
COMPLETEDCDH1 Germline Mutations in Lobular Breast CancerNCT04206891 · 2018-12-01
COMPLETEDHypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerNCT03414970 · 2018-03-12
ACTIVE_NOT_RECRUITINGBroccoli Sprout Extract in Treating Patients With Breast CancerNCT01753908 · 2013-05-21
COMPLETEDMonitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer TherapyNCT01038258 · 2007-07-01
UNKNOWNCommon interventions
Laboratory Biomarker AnalysisOTHER218F-Fluoroestradiol PET/CTDIAGNOSTIC_TEST118F-fluorofuranylnorprogesteroneDRUG168Ga-FAPI-46 PET scanDIAGNOSTIC_TEST1Adjuvant RadiotherapyRADIATION1Blood SpecimenPROCEDURE1Breast reconstruction decision aidOTHER1Broccoli Sprout ExtractDRUG1ChemotherapyDRUG1Crizotinib Oral Capsule [Xalkori]DRUG1Educational websiteOTHER1Endocrine TherapyDRUG1FESDRUG1Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic]DRUG1Hypofractionated Radiation TherapyRADIATION1Illumina panelDIAGNOSTIC_TEST1Liquid BiopsyDEVICE1Neoadjuvant endocrine therapyDRUG1Palliative radiotherapyRADIATION1PET scan after course 1 and surgery after 8 coursesPROCEDURE1PET/MRI APROCEDURE1Pharmacological StudyOTHER1PlaceboOTHER1Positron Emission Tomography/Computed TomographyDEVICE1Quality-of-Life AssessmentOTHER1
Leading sponsors
Memorial Sloan Kettering Cancer Center
3
European Institute of Oncology
2
Alliance for Clinical Trials in Oncology
1
Auxilio Mutuo Cancer Center
1
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
1
Istituto Oncologico Veneto IRCCS
1
Roswell Park Cancer Institute
1
Royal Marsden NHS Foundation Trust
1
Università Vita-Salute San Raffaele
1
University of California, San Francisco
1
University of Texas at Austin
1
University of Wisconsin, Madison
1
Trial status mix
RECRUITING6
ACTIVE_NOT_RECRUITING4
COMPLETED4
UNKNOWN1
Phase mix
NA4
PHASE24
EARLY_PHASE11
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.